Bosh sahifaGUD • TSE
add
Knight Therapeutics Inc
Yopilish kursi
6,13 $
Kunlik diapazon
6,10 $ - 6,22 $
Yillik diapazon
5,09 $ - 6,45 $
Bozor kapitalizatsiyasi
613,60 mln CAD
Oʻrtacha hajm
68,51 ming
Narx/foyda
144,46
Dividend daromadliligi
-
Asosiy maydon
TSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 96,86 mln | 30,55% |
Joriy xarajat | 43,31 mln | 26,28% |
Sof foyda | 10,74 mln | 144,13% |
Sof foyda marjasi | 11,08 | 133,79% |
Har bir ulushga tushum | 0,11 | 175,39% |
EBITDA | 6,46 mln | -17,88% |
Amaldagi soliq stavkasi | -36,32% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 172,84 mln | 1,75% |
Jami aktivlari | 963,80 mln | 1,94% |
Jami passivlari | 168,69 mln | -15,07% |
Umumiy kapital | 795,10 mln | — |
Tarqatilgan aksiyalar | 100,05 mln | — |
Narxi/balansdagi bahosi | 0,77 | — |
Aktivlardan daromad | -0,77% | — |
Kapitaldan daromad | -0,88% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 10,74 mln | 144,13% |
Operatsiyalardan naqd pul | 1,47 mln | -91,81% |
Sarmoyadan naqd pul | 18,05 mln | 1 049,45% |
Moliyadan naqd pul | -15,35 mln | 56,99% |
Naqd pulning sof oʻzgarishi | 6,35 mln | 134,04% |
Boʻsh pul | 4,96 mln | -91,80% |
Haqida
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Tashkil etilgan
2014
Bosh ofis
Sayt
Xodimlar soni
745
